Page 7 - Bharat Biotech

India-made Covid-19 vaccine Covaxin now on UK's approved travel list

Earlier this month, the Bharat Biotech manufactured Covaxin had received its WHO EUL status

Vaccine makers ramp up production capacities despite low current demand

Booster shot, children vaccination, exports can spike demand in the future

Developing Covaxin was an enormous challenge: Bharat Biotech

Bharat Biotech Director V Krishna Mohan said said there were no vaccines when Covid-19 hit India, and the world

Bharat Biotech's Covid-19 vaccine Covaxin gets mixed review from Lancet

Extrapolating from the report, Lancet said 'two doses offer 77.8 per cent protection against symptomatic Covid-19'.

Covid booster dose required if virus gets mutated: Bharat Biotech MD

India has done an amazing job, Dr Ella said on India surpassing the administration of 100 Crore vaccination

6 months post second dose ideal for booster: Bharat Biotech's Krishna Ella

The ideal time for a booster dose for COVID-19 vaccine is six months after the second dose, Bharat Biotech Chairman and Managing Director Krishna Ella said

Top headlines: Paytm IPO subscribed 1.89 times; Nykaa makes stellar debut

Business Standard brings you the top stories from today

SC to hear plea seeking disclosure of data on Covid shots' trials on Nov 29

The apex court had earlier in August asked the Centre, Bharat Biotech, SII, and others to respond to the plea which sought directions to also disclose post-vaccination data regarding adverse events

Covaxin for children will take some more time for final approval: Report

Recently, the Subject Expert Committee had given a recommendation to the DCGI for the use of Bharat Biotech's Covaxin Covid-19 vaccine for the beneficiaries aged between 2-18 years

LIVE: Merck's Covid pill secures green light from UK regulator

Live news updates: Bharat Biotech's home-grown Covid-19 vaccine now many be used for Covid-19 inoculation in poor countries.

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab

A big boost

Covaxin gets the stamp of international legitimacy

Top headlines: WHO clears Covaxin; Cairn cements end of tax dispute

Business Standard brings you the top headlines on Wednesday

'WHO's EUL status to Covaxin to accelerate equitable access of vaccine'

In a tweet, the WHO said it has granted emergency use listing (EUL) to Covaxin

WHO grants much-awaited emergency use listing to Bharat Biotech's Covaxin

Move will ease international travel for those vaccinated with the jab

Australia okays Bharat Biotech's Covaxin for travel ahead of WHO meet

The backing of Australia could tip the scale in favour of Covaxin when the WHO meets on November 3

Bharat Biotech's Covaxin recognised by Australia for travelers

Hyderabad-based Bharat Biotech's Covaxin, and AstraZeneca and Oxford University's Covishield are the two widely used vaccines in India

We trust India, Bharat Bio submitting data on EUL of Covaxin regularly: WHO

WHO official says the organisation is in touch with Bharat Biotech and has 'daily conversations' 'clarifying what additional data needs' to be submitted

Covaxin finds place in Oman's list of approved Covid-19 vaccines

Bharat Biotech tweeted, "Covaxin has now been added to the approved list of Covid-19 vaccines for travel to Oman without quarantine. This will facilitate travelers from India vaccinated with Covaxin."

WHO says likely to receive clarifications on Covaxin by weekend

WHO said it expects to receive clarifications from Bharat Biotech by the end of this week on its Covaxin -- and will meet on November 3 for a final risk-benefit assessment for Emergency Use Listing